These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7294550)

  • 1. Factitious heparin administration.
    Schmaier AH; Carabello JA; Day HJ; Barry WE
    Ann Intern Med; 1981 Nov; 95(5):592-3. PubMed ID: 7294550
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin and factitious purpura.
    Kim HC; Kosmin M
    Ann Intern Med; 1982 Mar; 96(3):377. PubMed ID: 7059105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in hemostasis in drug addicts].
    Arnalich F; Cuesta MV; Monereo A; García Muñoz S; Lahoz C; Fernández Pavón A; Peña JM
    Med Clin (Barc); 1988 Dec; 91(19):725-7. PubMed ID: 3236915
    [No Abstract]   [Full Text] [Related]  

  • 4. [TOLERANCE TEST TO HEPARIN IN VITRO].
    VELEZOROZCO A; CANIZARES C
    Bol Inst Estud Med Biol Univ Nac Auton Mex; 1963 Dec; 21():541-55. PubMed ID: 14120774
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of coagulation time of blood in normal and pathological subjects following intravenous administration of heparin (De Takats test)].
    DOTTI F; BONORA G
    Rass Int Clin Ter; 1950 Jun; 30(12):364-5. PubMed ID: 14781388
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa addiction and factitious disorder in a patient with idiopathic Parkinson's disease.
    Zaharna M; Pandya M
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352g.e11-352.e12. PubMed ID: 20686151
    [No Abstract]   [Full Text] [Related]  

  • 7. [DISORDERS OF BLOOD COAGULATION IN BURNS].
    LINTILHAC JP; SABLAYROLLES D
    Maroc Med; 1963 Sep; 42():679-81. PubMed ID: 14052111
    [No Abstract]   [Full Text] [Related]  

  • 8. [HYPERCOAGULABILITY AND A NEW HEPARIN LOADING TEST].
    BERKARDA B; DERMAN U
    Turk Tip Cemiy Mecm; 1963 Dec; 29():693-8. PubMed ID: 14101821
    [No Abstract]   [Full Text] [Related]  

  • 9. HEPARIN AND SOME COAGULATION FACTORS IN EXPERIMENTAL BURN INJURIES.
    JOHANSSON SA
    Acta Chir Scand; 1964 Oct; 128():346-9. PubMed ID: 14211289
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of heparin therapy.
    Pitney WR; Pettit JE; Armstrong L
    Br Med J; 1970 Oct; 4(5728):139-41. PubMed ID: 5475817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Raids into gastroenterology].
    Mathus-Vliegen EM; Tytgat GN
    Ned Tijdschr Geneeskd; 1984 Jan; 128(4):145-7. PubMed ID: 6700751
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relation between methamphetamine and amphetamine concentrations in the blood and symptoms in methamphetamine abusers].
    Miyazaki T
    Nihon Hoigaku Zasshi; 1986 Apr; 40(2):132-9. PubMed ID: 3784114
    [No Abstract]   [Full Text] [Related]  

  • 13. [JUVENILE HEMORRHAGES COMPLICATED BY DISORDERS OF THE BLOOD COAGULATION SYSTEM].
    ZAIATS LD; GUSEINOV ChS; LAGUTINA NIa; CHERNOV GA; IARUSTOVSKAIA LE
    Akush Ginekol (Mosk); 1964; 40():69-74. PubMed ID: 14183040
    [No Abstract]   [Full Text] [Related]  

  • 14. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 17. [New screening method for coagulation abnormality including AT III deficiency during CABG].
    Nakamura K; Hata T; Tsushima Y; Matsumoto M; Hamanaka S; Yoshitaka H; Morishita A; Shinoura S; Minami H; Ohtani S
    Kyobu Geka; 1999 Jul; 52(7):554-8. PubMed ID: 10402784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    COTTON RC; WADE EG
    Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427
    [No Abstract]   [Full Text] [Related]  

  • 19. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation time of blood heparinized in vitro: correlation of results with those of the heparin tolerance test.
    HAGEDORN AB; BARKER NW
    J Lab Clin Med; 1947 Sep; 32(9):. PubMed ID: 20267267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.